Loading...

Loading...

UNAM Breast Cancer Vaccines Move Toward Human Trials
By MBN Staff - Wed, 12/31/2025 - 12:16
UNAM researchers developed therapeutic breast cancer vaccines with preclinical success, clearing the path for future human trials.
https://mexicobusiness.news/tag/clinical-trials
More Health
The Global Cancer Burden and the Outlook for Latin America
By Guillaume Corpart - Mon, 12/15/2025 - 06:00
The outlook on cancer, both worldwide and in Latin America, is a complex story that includes both good news and bad news. Guillaume Corpart explains.
Global Trials Will Test AI-Engineered Antibody for Severe Asthma
By MBN Staff - Mon, 12/01/2025 - 17:37
Therapeutics company Generate:Biomedicines will begin global Phase 3 trials of GB-0895, an AI-designed antibody for severe asthma.
Oracle, Ci4CC Partner to Advance AI Innovation in Cancer Care
By MBN Staff - Mon, 11/10/2025 - 11:19
Oracle and Ci4CC join forces to use AI and data integration to enhance cancer care, research, and clinical trial innovation.
Can Regulatory Speed Unlock the Global R&D Vault for Mexico?
By Hector Salinas - Fri, 11/07/2025 - 06:00
To capitalize on global R&D momentum, Mexico must ensure regulatory harmonization becomes an operationalized reality, writes Héctor Salinas.
GSK to Multiply Clinical Research Investment in Mexico
By Sofía Garduño - Thu, 11/06/2025 - 11:50
GSK plans to increase its clinical research investment in Mexico tenfold, pending regulatory improvements.
Cumberland Pharmaceuticals Reports 12% Revenue Growth in 2025
By MBN Staff - Wed, 11/05/2025 - 17:52
Cumberland Pharmaceuticals reports 12% year-to-date revenue growth, driven by new partnerships and international expansion.
AI Is Revolutionizing Biopharma Innovation, Collaboration
By Oswaldo Bernal - Mon, 11/03/2025 - 08:30
GenAI is transforming the biopharmaceutical sector by accelerating scientific discovery while improving patient care, writes Oswaldo Bernal Carmona.
mRNA: From COVID Vaccine Savior to Cancer's Next Cure
By Luis Alberto Velez - Fri, 10/31/2025 - 08:00
mRNA is a paradigm shift, transforming how we think about treatment, prevention, and personalization in medicine, writes Luis Velez.
Neuraxpharm Expands Multiple Sclerosis Initiatives in Mexico
By Aura Moreno - Wed, 09/24/2025 - 13:42
Pharmaceutical company Neuraxpharm Group will showcase advances in the treatment of central nervous system (CNS) disorders at ECTRIMS 2025.